1.75
0.57%
-0.01
Finanzdaten der Aileron Therapeutics Inc-Aktie (ALRN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
1.17%
7.205
|
7.29 | 1.983 | 1.992 | 5.011 |
Operating Income/Loss |
1.17%
-7.205
|
-7.29 | -1.983 | -1.992 | -5.011 |
Income/Loss From Continuing Operations Before Tax |
3.08%
-7.113
|
-7.339 | -1.827 | -1.787 | -4.779 |
Income/Loss From Continuing Operations After Tax |
3.08%
-7.113
|
-7.339 | -1.827 | -1.787 | -4.779 |
Net Income/Loss
|
3.08%
-7.113
|
-7.339 | -1.827 | -1.787 | -4.779 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
14,326%
8.3018
|
0.0575 | 4.5412 | 4.5412 | 4.5412 |
Diluted Average Shares |
14,326%
8.3018
|
0.0575 | 4.5412 | 4.5412 | 4.5412 |
Basic Earnings Per Share |
45.22%
-0.86
|
-1.57 | -0.40 | -0.39 | -1.05 |
Diluted Earnings Per Share |
45.22%
-0.86
|
-1.57 | -0.40 | -0.39 | -1.05 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):